- Filed
- Apr 24, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 21, 2025 | 71.85M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $202.6M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $202.6M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $404.2M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $484.6M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $526.7M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $550.4M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $935.1M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $961.1M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.46B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.54B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.62B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.64B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 74.3M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $267M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $14.7M |
| Capex | Q1 2025 · Mar 31, 2024 | $90.6M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $118.2M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $2.68B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $2.88B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.55 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.57 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $86.7M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $17.6M |
| Net Income | Q1 2025 · Mar 31, 2024 | $115.3M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $122.8M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $230.2M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $465.2M |
| Revenue | Q1 2025 · Mar 31, 2024 | $695.4M |